Market Value2,633,516,000
Total Holdings77
File Date2015-05-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
CHRS / Coherus Oncology, Inc.
PRGO / Perrigo Company plc
ICPT / Intercept Pharmaceuticals Inc
GEVA / Synageva Biopharma Corp
AKRX / Akorn, Inc.
RLYP / Relypsa, Inc.
US0153511094 / Alexion Pharmaceuticals, Inc.
NKTR / Nektar Therapeutics
XLRN / Acceleron Pharma Inc
ENDP / Endo International plc
ZSPH / ZS Pharma, Inc.
OMED / OptMed Inc
H03579101 / Auris Medical Holding Ltd
CBM / Cambrex Corp.
NVS / Novartis AG - Depositary Receipt (Common Stock)
SHPG / Shire Plc.
PCRX / Pacira BioSciences, Inc.
HTWR / Heartware International Inc.
CLVS / Clovis Oncology Inc
MDVN / Medivation, Inc.
EGRX / Eagle Pharmaceuticals, Inc.
ASRT / Assertio Holdings, Inc.
AMPH / Amphastar Pharmaceuticals, Inc.
ALDR / Alder BioPharmaceuticals, Inc.
IMDZ / Immune Design Corp.
IPXL / Impax Laboratories, Inc.
US88165N2045 / Tetraphase Pharmaceuticals, Inc.
LCI / Lannett Co., Inc.
US60877T1007 / Momenta Pharmaceuticals, Inc.
NPSP / NPS Pharmaceuticals Inc
91911K102 / Bausch Health Companies
WX / Wuxi Pharmatech (Cayman) Inc.
KERX / Keryx Biopharmaceuticals, Inc.
G0083B108 / Actavis
INGN / Inogen, Inc.
US00448Q2012 / Achillion Pharmaceuticals, Inc.
RNA / Avidity Biosciences, Inc.
CBAY / CymaBay Therapeutics, Inc.
KPTI / Karyopharm Therapeutics Inc.
SESN / Sesen Bio Inc.
CELG / Celgene Corp.
CTLT / Catalent, Inc.
NVTA / Invitae Corporation
UHS / Universal Health Services, Inc.
ADXS / Ayala Pharmaceuticals, Inc.
HCA / HCA Healthcare, Inc.
TEVA / Teva Pharmaceutical Industries Limited - Depositary Receipt (Common Stock)
018490100 / Allergan plc
0PP / Portola Pharmaceuticals Inc
MCK / McKesson Corporation
US00C4U1L353 / Mylan N.V.
INCY / Incyte Corporation
PFE / Pfizer Inc.
ALGN / Align Technology, Inc.
SGEN / Seagen Inc
HZNP / Horizon Therapeutics Plc
UTHR / United Therapeutics Corporation
MNKKQ / Mallinckrodt Plc
CI / The Cigna Group
TNDM / Tandem Diabetes Care, Inc.
TGTX / TG Therapeutics, Inc.
ARAY / Accuray Incorporated
AMGN / Amgen Inc.
NXTM / NxStage Medical, Inc.
ALKS / Alkermes plc
ISRG / Intuitive Surgical, Inc.
SGNT / Sagent Pharmaceuticals, Inc.
QURE / uniQure N.V.
JAZZ / Jazz Pharmaceuticals plc
PTCT / PTC Therapeutics, Inc.
VRTX / Vertex Pharmaceuticals Incorporated
NVO / Novo Nordisk A/S - Depositary Receipt (Common Stock)
BIIB / Biogen Inc.
RDY / Dr. Reddy's Laboratories Limited - Depositary Receipt (Common Stock)
HALO / Halozyme Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
MDT / Medtronic plc
REGN / Regeneron Pharmaceuticals, Inc.
ABT / Abbott Laboratories
FOLD / Amicus Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
BMRN / BioMarin Pharmaceutical Inc.
DXCM / DexCom, Inc.
TMO / Thermo Fisher Scientific Inc.